免疫疗法和卵巢癌微环境:探索改善治疗疗效的潜在策略
Zhi-Bin Wang1,2, Xiu Zhang1,2, Chao Fang1,3
1Hunan Gynecological Tumor Clinical Research Center; Hunan Key Laboratory of Cancer Metabolism; Hunan Cancer Hospital, and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Immunology
|April 15, 2024
概括
由于瘤微环境,卵巢癌 (OC) 免疫疗法令人失望. 本综述探讨了免疫细胞行为和代谢变化,以提高OC免疫疗法的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 尽管癌症免疫疗法取得了进展,但卵巢癌 (OC) 的预后仍然很差.
- 瘤微环境 (TME) 显著影响OC免疫疗法的结果,将其归类为"冷瘤".
- 了解TME在OC免疫疗法的有效性中的作用至关重要.
研究的目的:
- 在OC TME中剖析各种免疫细胞的特征和行为.
- 探索OC免疫微环境中发生的重编程和代谢变化.
- 为提高OC免疫疗法的疗效提供理论基础.
主要方法:
- 文献综述侧重于OC TME的细胞和代谢方面.
- 分析瘤微环境中的免疫细胞相互作用和功能.
- 在OC免疫治疗的背景下检查代谢重编程.
主要成果:
- OC免疫微环境表现出复杂的细胞组成和相互作用.
- 在TME内的代谢变化显著影响免疫细胞功能和对治疗的反应.
- 特定的细胞行为和代谢途径被确定为免疫治疗结果的关键决定因素.
结论:
- 免疫微环境是OC免疫治疗成功的关键决定因素.
- 针对TME中的细胞重编程和代谢变化,为改善OC免疫疗法提供了有希望的策略.
- 对TME动态的进一步研究对于推进卵巢癌治疗至关重要.
相关概念视频
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
904
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904


